BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38699471)

  • 1. Double-blind, randomized, 8-week multicenter study of the efficacy and safety of STW 5-II
    Vinson B; Fink C; Wargenau M; Talley NJ; Holtmann G
    JGH Open; 2024 May; 8(5):e13054. PubMed ID: 38699471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis.
    Andresen V; Shah A; Fink C; Rabini S; Wargenau M; Holtmann G
    Digestion; 2024; 105(3):166-174. PubMed ID: 38246134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
    von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
    Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast®) in general practice.
    Michael R; Bettina V; Eckehard L
    Complement Ther Med; 2022 Dec; 71():102873. PubMed ID: 35998755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Xiao M; Zhong LLD; Lam WC; Zhao Y; Gwee KA; Holtmann G; Tack J; Suzuki H; Chen MH; Xiao Y; Hou X; Liu J; Li Y; Tang XD; Lu F
    Trials; 2022 Jun; 23(1):454. PubMed ID: 35655286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
    Braden B; Caspary W; Börner N; Vinson B; Schneider AR
    Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.
    Madisch A; Holtmann G; Plein K; Hotz J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):271-9. PubMed ID: 14984373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Herbal Formulation of Jiawei Xiaoyao for the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Placebo-Controlled, Clinical Trial.
    Chen G; Feng P; Wang S; Ding X; Xiong J; Wu J; Wang L; Chen W; Chen G; Han M; Zou T; Li L; Du H
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00241. PubMed ID: 33108123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chaihu-Shugan-San on functional dyspepsia and gut microbiota: A randomized, double-blind, placebo-controlled trial.
    Wang Y; Jia Y; Liu X; Yang K; Lin Y; Shao Q; Ling J
    J Ethnopharmacol; 2024 Mar; 322():117659. PubMed ID: 38151181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial.
    Kaosombatwattana U; Pongprasobchai S; Limsrivilai J; Maneerattanaporn M; Leelakusolvong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Feb; 33(2):411-417. PubMed ID: 28768370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
    Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical study on safety and efficacy of Naesohwajung-tang on functional dyspepsia.
    Ha NY; Kim S; Ko SJ; Park JW; Kim J
    Medicine (Baltimore); 2020 May; 99(21):e19910. PubMed ID: 32481255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].
    Raedsch R; Hanisch J; Bock P; Sibaev A; Vinson B; Gundermann KJ
    Z Gastroenterol; 2007 Oct; 45(10):1041-8. PubMed ID: 17924300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.
    Madisch A; Holtmann G; Mayr G; Vinson B; Hotz J
    Digestion; 2004; 69(1):45-52. PubMed ID: 14755152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Fingerroot (Boesenbergia rotunda) Extract in Patients with Functional Dyspepsia: A Randomized, Placebo-Controlled Trial.
    Chitapanarux T; Lertprasertsuke N; Toworakul C
    Digestion; 2021; 102(4):599-606. PubMed ID: 32998148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double-blind, placebo-controlled pilot study.
    Fang XC; Lin ZH; Wu YD; Tian A; Liu S; Wu DS; Lin H; Meng FD; Liu M; Du F; Shu HJ; Wang ZF; Zhuo JM; Wang P; Li MY; Xu J
    J Dig Dis; 2023 Nov; 24(11):603-610. PubMed ID: 37902019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia.
    Su Q; Chen SL; Wang HH; Liang LX; Dai N; Lyu B; Zhang J; Wang RQ; Zhang YL; Yu Y; Liu JS; Hou XH
    Chin Med J (Engl); 2018 Jul; 131(13):1549-1556. PubMed ID: 29941708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.